माल्टा - अंग्रेज़ी - Medicines Authority

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - imatinib mesilate - film-coated tablet - imatinib mesilate 400 mg - antineoplastic agents

माल्टा - अंग्रेज़ी - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - imatinib - film-coated tablet - imatinib - antineoplastic agents

माल्टा - अंग्रेज़ी - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - imatinib - film-coated tablet - imatinib 200 mg - antineoplastic agents

माल्टा - अंग्रेज़ी - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - imatinib - film-coated tablet - imatinib 300 mg - antineoplastic agents

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

viatris limited - imatinib mesilate 119.5mg equivalent to imatinib base 100 mg - film coated tablet - 100 mg - active: imatinib mesilate 119.5mg equivalent to imatinib base 100 mg excipient: colloidal silicon dioxide crospovidone hyprolose hypromellose iron oxide red iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose povidone purified talc purified water - - treatment of adult and paediatric patients with newly diagnosed philadelphia chromosome positive chronic myeloid leukaemia (ph+ cml) (for paediatric use see section dosage and administration). - treatment of adult and paediatric patients with ph+ cml in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy (for paediatric use see section dosage and administration).

सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - imatinib mesylate 119.5 mg eqv imatinib base - tablet, film coated - 100 mg - imatinib mesylate 119.5 mg eqv imatinib base 100 mg

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

viatris limited - imatinib mesilate 119.5mg equivalent to imatinib free base 100 mg - film coated tablet - 100 mg - active: imatinib mesilate 119.5mg equivalent to imatinib free base 100 mg excipient: colloidal silicon dioxide crospovidone hypromellose magnesium stearate microcrystalline cellulose opadry beige 85f97378 - imatinib mylan is indicated for the: - treatment of adult and paediatric patients with newly diagnosed philadelphia chromosome positive chronic myeloid leukaemia (ph+ cml) - treatment of adult and paediatric patients with ph+ cml in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy.

माल्टा - अंग्रेज़ी - Medicines Authority

generics uk limited - imatinib - film-coated tablet - imatinib 400 mg - antineoplastic agents

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - imatinib mesilate - film coated tablet - 400 milligram - protein kinase inhibitors

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - imatinib mesilate - film coated tablet - 100 milligram - protein kinase inhibitors